Keyphrases
2-cycles
16%
Antitumor Activity
16%
Area under the Curve
16%
Bone Marrow Transplantation
33%
Carboplatin
100%
Chemotherapy Regimen
16%
Congenital Malformations
16%
DNA Crosslinking Agents
16%
Fanconi Anemia
100%
Gemcitabine
100%
Hematopoietic Reconstitution
16%
Main Pulmonary Artery
16%
Malignancy
16%
Neoadjuvant Chemotherapy
100%
Neoadjuvant Therapy
33%
Non-small Cell Lung Cancer (NSCLC)
100%
Older Men
16%
Pancytopenia
16%
Pulmonary Vein
16%
Reduced Dose
100%
Right Lung
16%
Right Pneumonectomy
16%
Squamous Cell Carcinoma (SqCC)
16%
Treatment Toxicity
16%
Tumor
33%
Tumor Size
16%
Medicine and Dentistry
Antineoplastic Activity
16%
Bone Marrow Transplantation
33%
Cancer
16%
Carboplatin
100%
Congenital Malformation
16%
Fanconi Anemia
100%
Gemcitabine
100%
Isoprenaline
16%
Lobectomy
16%
Low Drug Dose
16%
Neoadjuvant Chemotherapy
100%
Neoadjuvant Therapy
33%
Neoplasm
50%
Non Small Cell Lung Cancer
100%
Non-Small Cell Lung Cancer
16%
Pancytopenia
16%
Pneumonectomy
16%
Pulmonary Artery
16%
Pulmonary Vein
16%
Right Lung
16%
Side Effect
16%
Squamous Cell Carcinoma
16%
Whole Body Radiation
16%